ACUTE LYMPHOBKASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBKASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBKASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBKASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis early-phase study aims to test the safety and initial effectiveness of an investigational drug called STR-P004 in adults with a specific type of acute lymphoblastic leukemia (ALL) that has returned or not responded to other treatments. The study will enroll a small group of …
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists stack therapies in 'Sandwich' attack on tough leukemia
Disease control Not yet recruitingThis study is testing a new multi-step treatment plan for adolescents and adults with B-cell acute lymphoblastic leukemia (B-ALL). The goal is to see if combining immunotherapy, a patient's own stem cell transplant, and a dual-target CAR-T cell therapy can better control the dise…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New 'Living Drug' trial offers hope for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized cell therapy for adults whose leukemia or lymphoma has returned or hasn't responded to standard treatments. Doctors will modify a patient's own immune cells to better target and fight their cancer, then infuse them back…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Doctors review past cases to gauge leukemia Drug's Real-World impact
Knowledge-focused Not yet recruitingThis study looks back at the medical records of about 100 adults with a specific type of leukemia (Philadelphia-positive ALL) who were already treated with the drug ponatinib as part of their regular care. The goal is to see how effective the treatment was in a real-world setting…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:26 UTC